Factors Associated With All-Cause Mortality Among Patients With Multidrug-Resistant Tuberculosis—United States, 1993–2013. (29th July 2017)

• Record Type: Journal Article
• Authors: Salinas, Jorge L; Armstrong, Lori R; Silk, Benjamin J; Haddad, Maryam B; Cegielski, J Peter
• Is Part Of: Clinical infectious diseases. Volume 65:Number 11(2017)
• Page Start: 1924
• Page End: 1926
• Publication Date: 2017-07-29
• Subjects: tuberculosis -- multidrug-resistant -- mortality -- United States; Communicable diseases -- Periodicals; 616.905
• DOI: 10.1093/cid/cix667
• Languages: English
• ISSNs: 1058-4838

Abstract

Abstract: We assessed characteristics associated with all-cause mortality among US patients with multidrug-resistant tuberculosis. Mortality decreased from 31% during 1993–2002 to 11% during 2003–2013. Directly observed therapy coverage increased from 74% to 95% and was protective against all-cause mortality after accounting for demographics, clinical characteristics, human immunodeficiency virus status, and period of treatment.